Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Gynaecological Cancers Congress 2023

AstraZeneca - Long-term survival for patients with newly-diagnosed advanced ovarian cancer (VIRTUAL ONLY)

Evidence from first-line PARPi maintenance trials

Date

23 Feb 2023

Session

AstraZeneca - Long-term survival for patients with newly-diagnosed advanced ovarian cancer (VIRTUAL ONLY)

Presenters

Kathleen Moore

Authors

K.N. Moore

Author affiliations

  • Stephenson Cancer Center/University of Oklahoma, Oklahoma City/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and introduction

Presenter: Nicoletta Colombo

Session: AstraZeneca - Long-term survival for patients with newly-diagnosed advanced ovarian cancer (VIRTUAL ONLY)

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.